NCT03315975Active, not recruitingPhase 4
Flu Vaccine Responses in the Setting of Melanoma Treatment
Influenza Vaccine Responses in the Setting of Melanoma Treatment
Source: ClinicalTrials.gov · Last updated 19 Aug 2025
Brief summary (registry, in English)
Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. We are conducting a prospective unblinded study of influenza vaccine recipients.
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- First submitted
- 16 Oct 2017
- Start date
- 20 Oct 2017
- Primary completion date
- 1 Jul 2026
- Lead sponsor
- University of Pennsylvania
- Diseases
- Melanoma
- NCT number
- NCT03315975
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 40
- From 20 Oct 2017 to the primary completion date, 1 Jul 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- have received influenza vaccination within the past 6 months
- require prednisone, methotrexate, or other immunosuppressing medications
- require combination immunotherapy
- are on other studies requiring blood draws that might exceed 450 mL total during the period of the influenza vaccine study
Other illness
- are allergic to influenza vaccination
- have HIV infection
- have a history of solid organ or bone marrow transplant
Who the study is looking for
- adults capable of providing consent
- have a diagnosis of locally advanced or metastatic melanoma
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Pennsylvania Coordinator of this site? Confirm its status | Philadelphia | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.